TP53 and neoplasm: Our results identified the upregulation of enzymatically active NMNAT as an essential metabolic regulator for promoting gliomagenesis and revealed that NMNAT-sustained PARylation and deacetylation of p53 results in suppression of apoptosis, a key tumor-inhibitory response.